Clinical Trials Logo

Late Onset Alzheimer Disease clinical trials

View clinical trials related to Late Onset Alzheimer Disease.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04838301 Recruiting - Clinical trials for Neurodegenerative Diseases

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

REGEN-BRAIN©
Start date: August 15, 2023
Phase: Phase 2
Study type: Interventional

A phase 2, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of Allopregnanolone as a regenerative therapeutic for Alzheimer's disease.

NCT ID: NCT00064870 Recruiting - Alzheimer Disease Clinical Trials

Alzheimer's Disease Genetics Study

NCRAD
Start date: June 2002
Phase:
Study type: Observational

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.